D3A — Benign neuroendocrine tumors

Not billable

Is D3A billable?

No — D3A is a non-billable header code. D3A groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 22 billable codes beneath D3A.

Billable codes under this header

D3A at a glance

Code	D3A
Description	Benign neuroendocrine tumors
Billable	No — header code
Code set	ICD-10-CM FY2027
Valid for encounters	October 1, 2026 – September 30, 2027

Use additional code

Report an additional code alongside D3A to fully describe the condition. D3A is sequenced first.

code to identify any associated endocrine syndrome, such as:
carcinoid syndrome (E34.00)

Excludes2 — not included here

The conditions below are not part of D3A, but a patient may have both at the same time. When documentation supports it, D3A and the excluded code may both be reported.

benign pancreatic islet cell tumors (D13.7)

Code also

Two codes may be needed to describe the condition fully. Whether D3A is sequenced first depends on the reason for the encounter.

any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

What codes fall under D3A? (2)

How long has D3A existed?

D3A has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.